Cadre Holdings, Inc. (CDRE) stock
CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3015% above fair value
$29.45−1.11 (-3.63%)
Close on Nov 20, 2026Market cap $1.26BP/E 36.4Yield 1.29%
Cadre gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Cadre's gross profit for the twelve months ending Jun 30, 2026 was $286.55M, up 20.6% year over year. For fiscal 2025 it was $259.63M, up 11.2% from the year before. The highest annual figure on record is $259.63M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $259.63M | +11.2% |
| FY2024 | Dec 31, 2024 | $233.48M | +16.3% |
| FY2023 | Dec 31, 2023 | $200.73M | +14.3% |
| FY2022 | Dec 31, 2022 | $175.68M | +2.9% |
| FY2021 | Dec 31, 2021 | $170.69M | +11.6% |
| FY2020 | Dec 31, 2020 | $152.94M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $87.14M | +35.6% |
| Q1 FY2026 | Mar 31, 2026 | $60.17M | +7.2% |
| Q4 FY2025 | Dec 31, 2025 | $72.62M | -5.9% |
| Q3 FY2025 | Sep 30, 2025 | $66.63M | +66.5% |
| Q2 FY2025 | Jun 30, 2025 | $64.25M | +9.5% |
| Q1 FY2025 | Mar 31, 2025 | $56.13M | -2.6% |
| Q4 FY2024 | Dec 31, 2024 | $77.19M | +55.1% |
| Q3 FY2024 | Sep 30, 2024 | $40.02M | -25.3% |
| Q2 FY2024 | Jun 30, 2024 | $58.65M | +15.6% |
| Q1 FY2024 | Mar 31, 2024 | $57.63M | +23.6% |
| Q4 FY2023 | Dec 31, 2023 | $49.76M | +2.5% |
| Q3 FY2023 | Sep 30, 2023 | $53.60M | +22.5% |
| Q2 FY2023 | Jun 30, 2023 | $50.75M | +17.4% |
| Q1 FY2023 | Mar 31, 2023 | $46.62M | +16.0% |
| Q4 FY2022 | Dec 31, 2022 | $48.53M | +23.8% |
| Q3 FY2022 | Sep 30, 2022 | $43.74M | +11.3% |
| Q2 FY2022 | Jun 30, 2022 | $43.22M | -10.4% |
| Q1 FY2022 | Mar 31, 2022 | $40.19M | -8.6% |
| Q4 FY2021 | Dec 31, 2021 | $39.20M | -1.5% |
| Q3 FY2021 | Sep 30, 2021 | $39.31M | -1.7% |
| Q2 FY2021 | Jun 30, 2021 | $48.23M | – |
| Q1 FY2021 | Mar 31, 2021 | $43.96M | – |
| Q4 FY2020 | Dec 31, 2020 | $39.79M | – |
| Q3 FY2020 | Sep 30, 2020 | $40.00M | – |
See a number that looks wrong?